Funded Tech Companies
I-Mab Biopharma
I-Mab Biopharma, based in Shanghai, has financial backing from Tasly Holding, CDH Investments and Edbi.
Company Overview
Company Name
I-Mab Biopharma
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
West Tower OmniVision 88 Shangke Rd. Pudong District 802
Shanghai, 201210
China
Shanghai, 201210
China
Phone
Website
Email Address
Company Background Information
Overview
I-Mab Biopharma was established through a merger of Third Venture Biopharma, an innovative antibody start-up, and Tasgen, a joint venture biotech by Tasly Pharmaceuticals, Genexine and C-Bridge Capital.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/30/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Jingwu Zang
Chief Executive Officer
Joan Shen
Chief Financial Officer
Jielun Zhu
General Manager
Neil Warma
Vice President
Douglas Chen
Vice President
Lili Qian
VP - Bus. Development
Raven Lin
VP - Bus. Development
Weimin Tang
VP - Manufacturing
Zheru Zhang
Company Investors
- Tasly Holding
- CDH Investments
- Edbi
- Ally Bridge Group
- Hillhouse Capital Group
- Hony Capital (Bing Yuan)
- HOPU Investments
- C-Bridge Capital (Wei Fu)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs